Aspirin News and Research

RSS
Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
New AHA Presidential Advisory addresses opioid use and its effects on heart and brain health

New AHA Presidential Advisory addresses opioid use and its effects on heart and brain health

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

Could aspirin intake reduce mortality risk in COVID-19 patients?

Could aspirin intake reduce mortality risk in COVID-19 patients?

World-first study uses artificial intelligence to map the risks of ovarian cancer in women

World-first study uses artificial intelligence to map the risks of ovarian cancer in women

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

Statin use among heart failure patients can reduce cancer risk

Statin use among heart failure patients can reduce cancer risk

Study determines the mechanism behind respiratory inflammation and finds effective treatment

Study determines the mechanism behind respiratory inflammation and finds effective treatment

Myocarditis after SARS-CoV-2 vaccine

Myocarditis after SARS-CoV-2 vaccine

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Daily intake of two or more sugar-sweetened drinks associated with higher bowel cancer risk

Daily intake of two or more sugar-sweetened drinks associated with higher bowel cancer risk

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Study shows why some stroke patients do not have abnormal heart rhythms

Study shows why some stroke patients do not have abnormal heart rhythms

NSAIDs could help mitigate the short-term impacts of air pollution on cognition

NSAIDs could help mitigate the short-term impacts of air pollution on cognition

Some COX inhibitors/NSAIDs increase COVID-19 severity

Some COX inhibitors/NSAIDs increase COVID-19 severity

Study shows adverse outcomes associated with use of more blood thinners

Study shows adverse outcomes associated with use of more blood thinners

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Researchers discover a new way to prevent brain nerve cells from deteriorating after injury

Researchers discover a new way to prevent brain nerve cells from deteriorating after injury

Early cardiac events pose major and different risks in close relatives, finds study

Early cardiac events pose major and different risks in close relatives, finds study

Long-term, regular use of baby aspirin may reduce risk of colorectal cancer death

Long-term, regular use of baby aspirin may reduce risk of colorectal cancer death

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.